Xiao Rong, Fu Guang, Li Xinglan, Lu Tao
Department of Radiology, Sichuan Provincial People's Hospital, University of Electronic Science and Technology of China, 32 West Second Section, First Ring Road, Chengdu, 610072, China.
Department of Pathology, Sichuan Provincial People's Hospital, University of Electronic Science and Technology of China, 32 West Second Section, First Ring Road, Chengdu, 610072, China.
World J Surg Oncol. 2025 Mar 29;23(1):106. doi: 10.1186/s12957-025-03757-7.
SWI/SNF-related, matrix-associated, actin-dependent regulator of chromatin, subfamily a, member 4-deficient non-small cell lung cancer (SMARCA4-dNSCLC) is a rare subtype of NSCLC whose definitive radiographic characteristics have not yet been fully delineated. Clinically, these tumors often metastasize to distant organs and lymph nodes at an early stage, which is strongly associated with poor clinical prognosis. The common metastatic sites include bone, brain, adrenal glands, liver, and spleen, whereas intestinal metastasis is extremely rare. In this case, we describe a rare instance of SMARCA4-deficient NSCLC with metastasis to the sigmoid colon.
A 59-year-old male presented with hoarseness and shortness of breath. Computed tomography (CT) imaging revealed an irregular mass in the posterior apical segment of the upper lobe of the left lung, with enlarged lymph nodes in the mediastinum and left lung hilum. A biopsy of the lung mass confirmed the diagnosis of NSCLC with SMARCA4 gene deletion. CT also revealed uneven thickening of the sigmoid colon wall, which was proved to be metastases from the lung cancer through surgical pathology. The patient initially underwent chemotherapy combined with immunotherapy and intensity-modulated radiotherapy for the lungs. However, a follow-up CT revealed progression in the sigmoid colon tumor. Consequently, the patient underwent laparoscopic radical sigmoid colectomy with regional lymph node dissection. Two months postoperatively, metastasis to the left adrenal gland was detected. The treatment regimen was adjusted to a combination therapy consisting of gemcitabine, nedaplatin, bevacizumab, and camrelizumab accordingly. The patient demonstrated a favorable response to this treatment, with no evidence of recurrence or further metastasis to date.
This case represents the first reported instance of SMARCA4-dNSCLC with metastasis to the sigmoid colon. The atypical clinical and radiological features of this condition pose significant diagnostic challenges, particularly in differentiating metastatic lesions from primary colonic tumors. This case underscores the significance of recognizing rare metastatic patterns in SMARCA4-dNSCLC, enriching the literature on its diverse manifestations and providing a critical reference for clinicians in diagnosing and managing SMARCA4-dNSCLC with sigmoid colon metastasis.
SWI/SNF相关、基质相关、肌动蛋白依赖的染色质调节因子a亚家族成员4缺陷型非小细胞肺癌(SMARCA4缺陷型非小细胞肺癌,SMARCA4-dNSCLC)是一种罕见的非小细胞肺癌亚型,其明确的影像学特征尚未完全明确。临床上,这些肿瘤通常在早期就转移至远处器官和淋巴结,这与不良的临床预后密切相关。常见的转移部位包括骨骼、脑、肾上腺、肝脏和脾脏,而肠道转移极为罕见。在此病例中,我们描述了一例罕见的SMARCA4缺陷型非小细胞肺癌转移至乙状结肠的病例。
一名59岁男性因声音嘶哑和呼吸急促就诊。计算机断层扫描(CT)成像显示左肺上叶尖后段有一不规则肿块,纵隔和左肺门淋巴结肿大。肺肿块活检确诊为伴有SMARCA4基因缺失的非小细胞肺癌。CT还显示乙状结肠壁不均匀增厚,经手术病理证实为肺癌转移。患者最初接受了针对肺部的化疗联合免疫治疗及调强放疗。然而,随访CT显示乙状结肠肿瘤进展。因此,患者接受了腹腔镜下乙状结肠癌根治术及区域淋巴结清扫术。术后两个月,检测到左肾上腺转移。治疗方案相应调整为吉西他滨、奈达铂、贝伐单抗和卡瑞利珠单抗的联合治疗。患者对该治疗反应良好,迄今为止无复发或进一步转移的迹象。
本病例是首例报道的SMARCA4-dNSCLC转移至乙状结肠的病例。这种情况非典型的临床和放射学特征带来了重大的诊断挑战,尤其是在区分转移性病变与原发性结肠肿瘤方面。本病例强调了认识SMARCA4-dNSCLC罕见转移模式的重要性,丰富了其多样表现的文献,并为临床医生诊断和治疗伴有乙状结肠转移的SMARCA4-dNSCLC提供了关键参考。